HAE
Haemonetics Corporation Healthcare - Medical Devices Investor Relations →
Haemonetics Corporation (HAE) closed at $58.58 as of 2026-03-20, trading 23.3% below its 200-week moving average of $76.37. This places HAE in the extreme value zone. The stock is currently moving closer to the line, down from -21.6% last week. With a 14-week RSI of 20, HAE is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.65 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 1771 weeks of data, HAE has crossed below its 200-week moving average 39 times. On average, these episodes lasted 15 weeks. Historically, investors who bought HAE at the start of these episodes saw an average one-year return of +5.1%.
With a market cap of $2.7 billion, HAE is a mid-cap stock. The company generates a free cash flow yield of 12.2%, which is notably high. Return on equity stands at 19.3%, a solid level. The stock trades at 3.0x book value.
The company has been aggressively buying back shares, reducing its share count by 5.7% over the past three years.
Over the past 33.2 years, a hypothetical investment of $100 in HAE would have grown to $430, compared to $2683 for the S&P 500. HAE has returned 4.5% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 23.4% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: HAE vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After HAE Crosses Below the Line?
Across 39 historical episodes, buying HAE when it crossed below its 200-week moving average produced an average return of +3.2% after 12 months (median +0.0%), compared to +20.1% for the S&P 500 over the same periods. 49% of those episodes were profitable after one year. After 24 months, the average return was +17.9% vs +36.2% for the index.
Each line shows $100 invested at the moment HAE crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
HAE has crossed below its 200-week MA 39 times with an average 1-year return of +5.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 1992 | May 1992 | 3 | 6.6% | +20.0% | +733.1% |
| Apr 1993 | Apr 1993 | 1 | 0.5% | +13.3% | +594.3% |
| Apr 1994 | May 1994 | 6 | 13.6% | -4.5% | +610.1% |
| Jun 1994 | Oct 1994 | 18 | 23.0% | -3.9% | +516.6% |
| Dec 1994 | Jun 1995 | 28 | 26.3% | -6.0% | +529.0% |
| Jul 1995 | Jul 1995 | 1 | 0.5% | -6.6% | +516.6% |
| Oct 1995 | Aug 1996 | 43 | 17.0% | -4.2% | +550.9% |
| Oct 1996 | Jun 1997 | 37 | 17.1% | -4.9% | +555.4% |
| Jul 1997 | Sep 1997 | 10 | 11.3% | -14.9% | +535.4% |
| Oct 1997 | Mar 1998 | 25 | 24.0% | +3.3% | +589.2% |
| Apr 1998 | Sep 1998 | 21 | 15.3% | -10.4% | +569.5% |
| Oct 1998 | Oct 1998 | 1 | 0.1% | +11.7% | +567.1% |
| Feb 1999 | May 1999 | 13 | 18.9% | +44.7% | +581.7% |
| Jul 1999 | Jul 1999 | 1 | 0.7% | +28.6% | +562.4% |
| Jul 2002 | Aug 2002 | 3 | 4.4% | -25.2% | +378.2% |
| Sep 2002 | Jan 2004 | 71 | 35.5% | -14.0% | +353.4% |
| May 2004 | May 2004 | 3 | 3.1% | +52.3% | +348.5% |
| Jul 2004 | Jul 2004 | 1 | 0.4% | +51.2% | +332.8% |
| Mar 2009 | May 2009 | 6 | 2.2% | +10.2% | +128.7% |
| Oct 2009 | Nov 2009 | 1 | 2.3% | +6.1% | +127.5% |
| May 2010 | Jun 2010 | 1 | 0.3% | +23.6% | +119.0% |
| Jun 2010 | Jun 2010 | 1 | 0.1% | +17.5% | +118.1% |
| Aug 2010 | Aug 2010 | 3 | 3.0% | +13.9% | +122.3% |
| Nov 2011 | Nov 2011 | 1 | 4.8% | +49.0% | +113.0% |
| Mar 2014 | Aug 2014 | 19 | 11.8% | +37.7% | +82.4% |
| Aug 2014 | Oct 2014 | 9 | 5.6% | +0.7% | +64.1% |
| Aug 2015 | Nov 2016 | 64 | 31.3% | -3.6% | +56.5% |
| Aug 2020 | Aug 2020 | 1 | 2.8% | -26.7% | -26.6% |
| Sep 2020 | Sep 2020 | 1 | 0.9% | -15.3% | -29.3% |
| Apr 2021 | May 2023 | 110 | 52.2% | -19.9% | -13.2% |
| Jun 2023 | Jul 2023 | 5 | 3.1% | +1.0% | -30.1% |
| Nov 2023 | Nov 2023 | 1 | 0.8% | +4.4% | -28.5% |
| Jan 2024 | Jan 2024 | 1 | 0.4% | -1.7% | -28.1% |
| Jan 2024 | Mar 2024 | 9 | 10.9% | -12.9% | -27.9% |
| Aug 2024 | Nov 2024 | 13 | 8.4% | -29.9% | -24.0% |
| Dec 2024 | Dec 2024 | 1 | 1.4% | +6.3% | -22.3% |
| Jan 2025 | Jun 2025 | 24 | 23.6% | -1.8% | -20.3% |
| Jul 2025 | Nov 2025 | 18 | 35.6% | N/A | -19.3% |
| Jan 2026 | Ongoing | 10+ | 24.2% | Ongoing | -18.8% |
| Average | 15 | — | +5.1% | — |
Frequently Asked Questions
Is HAE below its 200-week moving average?
Yes. As of 2026-03-20, Haemonetics Corporation (HAE) is trading 23.3% below its 200-week moving average of $76.37. The current price is $58.58.
What is HAE's 200-week moving average price?
Haemonetics Corporation's 200-week moving average is $76.37 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when HAE drops below its 200-week moving average?
HAE has crossed below its 200-week moving average 39 times in our data. On average, buying at that moment produced a one-year return of +5.1%. These dips have historically been decent entry points. These episodes lasted 15 weeks on average.
Is HAE a good value right now?
Here's what our data says about HAE as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 20 (oversold). Free cash flow yield is 12.2%. Return on equity is 19.3%. Price-to-book is 3.0x. This is not a buy or sell recommendation — always do your own research.
How does HAE compare to the S&P 500?
Over the past 33.2 years, $100 invested in HAE would have grown to $430, compared to $2683 for the S&P 500. That's 4.5% annualized vs 10.4% for the index. HAE has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20